MedPath

“A Comparative Clinical Study OfYashtimadhu Ghrita And Lignocaine-Nifedipine Ointment In The Management Of Parikartika (Acute Fissure- In- Ano).â€

Phase 1/2
Recruiting
Conditions
PARIKARTIKA ( ACUTE FISSURE IN ANO)
Registration Number
CTRI/2016/11/007496
Lead Sponsor
IPGT AND RA GAU JAMNAGAR
Brief Summary

This study is open label comparative clinical study of local application of yashtimadhu ghrita and lignocaine-nifedipine in the management of parikartika (acute fissure in ano)

Routine blood investigations will be performed to rule out others .

special scoring scale has been prepared based on information in

ayurvedic  classical texts which will be utilized for assessment and evaluation



**METHOD:**

·         **Grouping** **of Patients :**

The patients shall be randomly allocated into two groups A & B, having minimum 15 patients in each group.

**Group-A:**  Local application of *Yashthimadhu Ghrita* in fissure bed (*Parikartika*) twice a day after sitz bath for 4 weeks.

**Group-B:**  Local application of Lignocaine-nifedipine ointment in fissure bed *Parikartika* twice a day after sitz bath for 4 weeks.

·         **Common Treatment for both groups:**

**1.** Warm water sitz bath with *Panchavalkal Kwath*, twice a day.

2.  *Erandbhrist Haritaki Churna* 5gms HS (at bed time) with luke warm water.

·         **Procurement of trial drugs**

*Yashtimadhu ghrit*will be procured from pharmacy of Gujrat Ayurved University, Jamnagar.

Lignocaine-nifedipine ointment (anobliss or any branded ointment) will be procured from local market.

·         **Duration of treatment**

Four weeks

·         **Follow-up Period:** One month

·         **Laboratory Investigation:**

a.     CBC

b.     RBS,

c.     Blood urea, Sr. Creatinine, Sr. Billirubin.

e.     HIV, VDRL, HBsAg

f.     Urine analysis- Routine & Microscopic

g.     Stool examination- Routine & Microscopic

·         **Other Investigation:**

Chest X-Ray, ECG, USG Abdomen, Colonoscopy if required.

**OVERALL ASSESSMENT** **CRITERIA:**

Patients will be assessed as per following gradation:

1. Complete remission: 100 % improvement in subjective and objective parameter

2. Marked improvement: 76 – 99 % relief in subjective and objective parameter

3. Moderate improvement: 51 - 75 % relief in subjective and objective parameter

4. Mild improvement: 26 - 50 % relief in subjective and objective parameter

5. Unchanged: Less than 25 % relief in subjective and objective parameter

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
30
Inclusion Criteria
  • 1.Patients of Parikartika (Acute fissure-in-ano) having duration less than 12 weeks.
  • 2.Controlled cases of Diabetese mallitus or Hypertension.
Exclusion Criteria
  • 1.Fissure-in-ano having duration- more than 12 weeks.
  • 2.Patient below 17 & above 70 years of age.
  • 3.Patient suffering from malignancy.
  • 4.Patient suffering from HIV, VDRL, Hepatitis-B, T.B. 5.Fissure-in-ano associated with piles & fistula.
  • 6.Multiple fissure in ano 7.Uncontrolled cases of Diabetes Mellitus and Hypertension.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ASSESSMENT WILL BE DONE ON THE BASIS OF SPECIALLY PREPARED PERFORMA FOR ASSESSING RELIEF IN SIGN AND SYMPTOMS BY SCORING PATTERNASSESSMENT WILL BE DONE ON THE BASIS OF SPECIALLY PREPARED PERFORMA FOR ASSESSING RELIEF IN SIGN AND SYMPTOMS BY SCORING PATTERN
Secondary Outcome Measures
NameTimeMethod
1 MONTH1 MONTH

Trial Locations

Locations (1)

IPGT AND RA GAU

🇮🇳

Jamnagar, GUJARAT, India

IPGT AND RA GAU
🇮🇳Jamnagar, GUJARAT, India
JIGNA PATEL
Principal investigator
9033307475
dr.jignapatel48@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.